Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A research notebook and pen in a lab setting

Jun 3, 2026

Accelerating life sciences research with Kiro: A unified AI interface to 100+ open source databases

Researchers in life sciences often grapple with the daunting task of integrating data from numerous databases, each with unique access protocols and formats. Kiro for Life Sciences addresses this challenge by offering a unified AI interface that connects over 100 databases across 24 disciplines, enabling researchers to query multiple sources simultaneously using natural language.The integration of disparate databases can be overwhelming. For example, a researcher studying BRCA1 variants may need
A minimalist representation of a pill bottle and a data chart in flat design.

Jun 3, 2026

LiveWorld Launches LiveInsight AI™, Creating a New Category of Intelligence Systems for Pharma

LiveWorld has introduced LiveInsight AI™, an innovative intelligence system tailored for the pharmaceutical industry, designed to convert complex healthcare data into actionable insights rapidly.Launching with 12 patents pending, LiveInsight AI™ distinguishes itself by addressing the limitations of existing approaches in pharma marketing. Traditional AI tools often lack the necessary healthcare context, while social listening platforms fail to provide strategic insights. LiveInsight AI™ utilizes
A biological sample viewed through a microscope in a dimly lit lab.

Jun 3, 2026

OpenAI Brings AI Into Bio-Weapons Detection and Preparedness

OpenAI is advancing its efforts in biodefense by providing select government and allied partners with access to its AI model, GPT-Rosalind, aimed at enhancing biological threat preparedness.This initiative is part of OpenAI's broader biodefense program, which focuses on leveraging artificial intelligence to support critical functions such as outbreak modeling, early detection of biological threats, and planning for preparedness. The program aims to assist in the development of medical countermea
A physiotherapy model demonstrating a back exercise in a dimly lit consultation room.

Jun 3, 2026

Flok Health raises £9.5m to scale its AI clinician - UKTN

Flok Health has successfully secured £9.5 million ($12.5 million) in a Series A funding round, aimed at enhancing its AI-driven physiotherapy services.The innovative clinic operates autonomously, providing comprehensive healthcare pathways without human intervention. Currently, it caters to NHS patients, offering immediate access to back pain consultations via a mobile app, eliminating traditional wait times. The AI system utilizes real footage of physiotherapists to create an interactive experi
A flat illustration of a medical device silhouette on a solid background.

Jun 3, 2026

Costa Rica’s US$10bn medtech boom defies global investment chill

Costa Rica is emerging as a pivotal player in the global medical technology landscape, even as worldwide investment in life sciences wanes. According to Marianela Urgellés, managing director of CINDE, the country is advancing beyond traditional manufacturing into areas like AI-driven healthcare and advanced R&D.As the medical technology sector undergoes a transformation, Costa Rica has positioned itself as a hub for innovation. With over US$10 billion in medical device exports, the nation has be
A blood sample in a vial on a lab bench with medical supplies in the background.

Jun 3, 2026

Leveraging Precision Diagnostics, AI and Data‑Led Decision‑Making

The healthcare landscape is shifting from reactive treatment to proactive care, driven by advancements in precision diagnostics, AI, and data-led decision-making.This transformation emphasizes early and accurate disease detection, with precision diagnostics playing a central role in clinical workflows. Technologies like blood-based diagnostics are crucial for identifying early signs of conditions such as infections and chronic diseases, thereby facilitating timely interventions that improve pati
A blood smear on a microscope slide in a lab setting

Jun 3, 2026

AI-Powered Pathology Research Advances Diagnostics In South Africa

The National Health Laboratory Service (NHLS) in South Africa is embarking on an ambitious initiative to integrate artificial intelligence (AI) into pathology research, aiming to enhance diagnostic accuracy and efficiency within the public healthcare system.This initiative is part of a broader strategy to modernize laboratory medicine, with a particular focus on haematopathology. Traditionally, diagnosing conditions like multiple myeloma has been labor-intensive and subject to variability, espec
Flat design of TROP2 biomarker and assay

Jun 3, 2026

Leica Biosystems Announces Expansion of Collaboration to Scale Precision Medicine and Develop AI-Powered Diagnostics

Leica Biosystems is enhancing its collaboration with AstraZeneca and Daiichi Sankyo to advance precision medicine through the development of AI-driven diagnostics for non-small cell lung cancer.The expansion of this partnership, initially established in May 2025, focuses on the creation of an immunohistochemistry (IHC) assay and image analysis algorithm targeting the TROP2 Normalized Membrane Ratio (NMR) biomarker. This initiative aims to provide a comprehensive research tool that integrates bot
A minimalist illustration of a clipboard with a checkmark, symbolizing clinical processes.

Jun 3, 2026

Medable Launches Agentic Accelerator Program to Help Life Sciences Companies Deploy Agentic AI Across Clinical Lifecycle

Medable has introduced its Agentic Accelerator Program aimed at enhancing clinical development through agentic AI technology.The new program is designed to assist life sciences companies, including sponsors and contract research organizations (CROs), in effectively integrating agentic AI into their clinical processes. It offers comprehensive support that encompasses onboarding, governance, and change management, ensuring that organizations can derive value from AI from the outset. Notably, despi
A petri dish with cultured cells on a laboratory bench in a dimly lit lab.

Jun 3, 2026

Helsinki Invites International Companies to Explore R&D Partnerships in Life Sciences and AI & Deep Tech

Helsinki is actively inviting global companies to engage in R&D partnerships within its life sciences and AI sectors through the 90 Hour Helsinki Program.This initiative, organized by Helsinki Partners, the City of Helsinki, and the University of Helsinki, aims to facilitate collaboration by connecting international firms with local research and innovation clusters. The program provides a platform for decision-makers to explore Finland's business ecosystem, addressing common barriers like talent
A minimalist illustration of a molecule representing drug development.

Jun 3, 2026

Ingenix Raises €13m From Sofinnova Partners-Led Syndicate to Scale Modality Fusion, a Novel Architecture for Drug Development

Ingenix has successfully secured €13 million in funding to advance its innovative Biological Reasoning Engine, which utilizes a novel AI architecture called Modality Fusion for drug development.This funding round, led by Sofinnova Partners with additional contributions from Inovo VC and OTB VC, aims to enhance Ingenix's collaborations with pharmaceutical and biotech companies through its newly launched Qualified Access Program. The Biological Reasoning Engine has demonstrated impressive capabili
A biological data model on a lab table with research equipment in the background.

Jun 3, 2026

Ingenix raises €13m to scale AI drug development engine

Ingenix has successfully secured €13 million in funding to enhance its AI-driven drug development capabilities, building on a previous €9 million seed round. This investment aims to expand the company's Biological Reasoning Engine, a sophisticated AI tool designed to facilitate translational and clinical research decisions, while also increasing collaboration opportunities with pharmaceutical and biotech partners.Founded in 2023, Ingenix is pioneering an innovative approach known as Modality Fus